Hear what our digital attendees have to say about our virtual meetings 

“Good mixture of excellent talks and discussions! Almost like being on a F2F conference!"

Chief Research & Development Officer, CombiGene

"I think what was here was excellent. So, don't change it. Especially the software."

Executive Director, Sarepta Therapeutics

"It was very informative and worked exceptionally well as a remote meeting."

Senior Director, Translational Medicine, EMEA, AveXis

"I have to say that I was initially sceptical of an online meeting, but it was so well organized that it almost felt like you were there in person and the sessions moved flawlessly.”

Head of Search and Evaluation, Cerevel Therapeutics

“Very efficiently organized - considering it was virtual - excellent speakers.”

CEO, Eyevensys

“Very well organized and informative virtual conference!”

Senior Director - Regulatory Affairs, Adverum

“Exciting new way of participating in scientific conference and discussion.”

Vice President - New Therapeutic Targets Discovery, uniQure

“Informative and enjoyable, the web interface worked well. The future of conferencing.”

Associate Director - Regulatory Affairs, Biologics & Advanced Therapy Medicinal Products, Diamond Pharma Services

“Inspiring virtual meeting allowing efficient learning about the most recent advances in Gene Therapy Immunogenicity while still having interactions with peers.”

Director - Safety Science Group Medical, Roche

Hear what our previous attendees have to say about Gene Therapy for Rare Disorders meetings

‘The conference was very well attended and very informative to a wider industry audience; not just manufacturing, but clinical and commercialization as well’

Vertex Pharmaceuticals

‘Outstanding networking. Pleasure to find opportunities for cross functional learning amongst peers. High quality speakers, outstanding job’


‘This is one of the best meetings I have ever attended. It was a crash course in everything AAV from manufacturing through clinical applications and commercialization. The quality of the speakers was top notch. The networking was very efficient, and the organization was impeccable’


‘Best conference of the year for gene therapy companies to understand how our industry is tackling the challenges of pioneering the development of our advanced therapy products’


‘The conference really brought the industry leaders together and provided an excellent opportunity to learn and monitor the pulse of the field’


‘Excellent and focussed gathering of people passionate about curing rare disease’


‘This was a truly excellent event. A fantastic agenda covering all aspects of gene therapy in rare disorders with expert speakers and real learning and sharing atmosphere’

Emotive Agency

‘The industry segment was very well represented at the event, with startups, big pharma, CDMOs, A&E firms, consultancies, academia, OEMs, and patient advocates all in attendance. I was able to get the full picture view I was after’

Bosch Packaging Technology

‘First time we participated at this meeting. All the main players in Cell and Gene Therapy were gathered. Perfectly organized, good size to meet and network. I'll consider coming back in 2020... we all should!’


‘This meeting was an excellent opportunity to sit with leaders from around the industry discussing the challenges and success in the gene therapy realm in 2019.’


‘This was my first conference, and I had such a great overall learning experience! Can’t wait for next year!’

High Purity New England